Group Sequential Methods with Applications to Clinical Trials¶
Jennison, C., & Turnbull, B. W. (2000). Group Sequential Methods with Applications to Clinical Trials. Chapman & Hall.
Cited by¶
2 citations across 2 artifacts.
Each citation links to the sentence it supports in the citing article.
Primes¶
- Optimal Stopping Rule
- In statistics, sequential analysis and group-sequential clinical-trial designs with futility and efficacy boundaries operationalize stopping for ethical and resource reasons.
This sourceStandard reference on sequential analysis and group-sequential designs with interim looks, accumulating test statistics, and futility/efficacy stopping boundaries.
Supported in partVerified against the publisher's abstract
Its abstract states group sequential methods balance the ethical and financial advantages of stopping a study early, backing the statistics half of the claim, but not the 'futility and efficacy boundaries' wording or the mathematics half.
“Group sequential methods provide a means to balance the ethical and financial advantages of stopping a study early against the risk of an incorrect conclusion.”
- In statistics, sequential analysis and group-sequential clinical-trial designs with futility and efficacy boundaries operationalize stopping for ethical and resource reasons.
- Termination Condition
- The branch-and-bound termination vocabulary — gap closure, bound improvement — maps directly to group-sequential trial design with its efficacy and futility bounds, with parallel mathematical structure and parallel optional-stopping pathologies, so an algorithm designer's stopping intuition becomes a trial statistician's.
This sourceStandard reference for group-sequential designs with efficacy and futility boundaries and a maximum sample size as the termination structure.
Supported in partVerified against the publisher's abstract
The abstract supplies group-sequential stopping rules that reduce study length and control Type I/II error, but nothing on branch-and-bound gap closure or the claimed parallel structure.
“Group Sequential Methods with Applications to Clinical Trials describes group sequential stopping rules designed to reduce average study length and control Type I and II error probabilities.”
- The branch-and-bound termination vocabulary — gap closure, bound improvement — maps directly to group-sequential trial design with its efficacy and futility bounds, with parallel mathematical structure and parallel optional-stopping pathologies, so an algorithm designer's stopping intuition becomes a trial statistician's.
Verification¶
Does it exist? Confirmed. This work's DOI resolves to a registered record, which fixes its identity. That is all it fixes.
Does it back the claim? Read against the text for 2 of 2 citations: 2 supported in part. Each verdict is shown under its citation below, with what in the work backs the sentence.
Support is checked per citation rather than per work — the same source can be cited soundly in one article and wrongly in another. Per-citation recording began recently, so a citation with no recorded check is a gap in the record rather than evidence it went unchecked.
See how references were verified.
Links previously used in the corpus¶
Before the registry existed this work was also linked 1 other way.
Registry ID ref:c5207ce6ee14 · see in the full table